Posted: January 25th, 2023
THIS DISCUSSION IS DIVIDE IN TWO PARTS –
0. MAIN DISCUSSION POST BY WEDNESDAY 01/25/2023 BEFORE 8:00 PM EST
0. TWO REPLIES BY FRIDAY 01/27/2023 BEFORE 8:00 PM EST
PRESCRIBING FOR OLDER ADULTS AND PREGNANT WOMEN
After assessing and diagnosing a patient, PMHNPs must take into consideration special characteristics of the patient before determining an appropriate course of treatment. For pharmacological treatments that are not FDA-approved for a particular use or population, off-label use may be considered when the potential benefits could outweigh the risks.
In this Discussion, you will investigate a specific disorder and determine potential appropriate treatments for when it occurs in an older adult or pregnant woman.
TO PREPARE:
· Choose one of the two following specific populations: either pregnant women or older adults. Then, select a specific disorder from the DSM-5-TR to use.
· Research evidence-based treatments for your selected disorder in your selected population (either older adults or pregnant women). You will need to recommend one FDA-approved drug, one non-FDA-approved “off-label” drug, and one non-pharmacological intervention for treating the disorder in that population.
Instructions
· Recommend one FDA-approved drug, one off-label drug, and one non-pharmacological intervention for treating your chosen disorder in older adults or pregnant women.
· Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
· Explain whether clinical practice guidelines exist for this disorder, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
· Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a non-pharmacological intervention for the disorder.
Weekly Resources
· American Psychiatric Association. (2016). The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia Links to an external site. . https://doi.org/10.1176/appi.books.9780890426807
· Agency for Healthcare Research and Quality. (2019). Maternal and fetal effects of mental health treatments in pregnant and breastfeeding women: A systematic review of pharmacological interventions Links to an external site. . https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
SOLUTION
When prescribing medication for older adults and pregnant women, it is important to consider the potential for increased sensitivity to certain medications and potential drug interactions. It is also important to consider the potential risks to the developing fetus in pregnant women.
It is generally recommended to use the lowest effective dose and to avoid using multiple medications if possible. It is also important to regularly monitor and reassess the individual’s response to the medication to ensure it is still the best treatment option. It is also recommended to consult with a specialist when prescribing for these populations.
Place an order in 3 easy steps. Takes less than 5 mins.